AZD 0275

Drug Profile

AZD 0275

Alternative Names: AZD0275

Latest Information Update: 28 Oct 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator AstraZeneca
  • Class
  • Mechanism of Action Chemokine receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Chronic obstructive pulmonary disease; Rheumatoid arthritis

Most Recent Events

  • 28 Oct 2003 Discontinued - Preclinical for Chronic obstructive pulmonary disease (unspecified route)
  • 28 Oct 2003 Discontinued - Preclinical for Rheumatoid arthritis (unspecified route)
  • 04 Jul 2003 Preclinical trials in Rheumatoid arthritis (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top